Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Predicting risks and benefits...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Predicting risks and benefits of treatment with aspirin in the acute stage of ischaemic stroke: an individual patient data meta-analysis of 39,166 patients in 3 large randomised controlled trials
Bibliographic Details
Main Authors:
Whiteley, W
,
Candelise, L
,
Chen, Z
,
Sandercock, P
Format:
Journal article
Published:
2013
Holdings
Description
Similar Items
Staff View
Similar Items
Indications for early aspirin use in acute ischaemic stroke: A combined analysis of over 40,000 randomised patients
by: Chen, Z, et al.
Published: (1999)
CAST: Randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke
by: Chen, Z, et al.
Published: (1997)
Immediate aspirin for suspected ischaemic stroke.
by: Baigent, C, et al.
Published: (1999)
The International Stroke Trial (IST): A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke
by: Sandercock, P, et al.
Published: (1997)
Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials
by: Rothwell, PM, et al.
Published: (2016)